Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 13 Schemes (15.7%)
Foreign Institutions
Held by 14 Foreign Institutions (3.91%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Mar 2026)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 286 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.78
-999,999.00%
2.03






